☆ 4.3 Article

Lipidomic analysis identified potential predictive biomarkers of statin response in subjects with Familial hypercholesterolemia

CHEMISTRY AND PHYSICS OF LIPIDS (2023)

Related references

Note: Only part of the references are listed.

Article Genetics & Heredity

LDLR missense variants disturb structural conformation and LDLR activity in T-lymphocytes of Familial hypercholesterolemia patients

Thais Kristini Almendros Barbosa et al.

Summary: Familial hypercholesterolemia (FH) is caused by harmful mutations in the LDLR gene, resulting in significantly increased low-density lipoprotein (LDL) cholesterol and premature atherosclerotic cardiovascular disease. In this study, the functional effects of LDLR variants in Brazilian FH patients were assessed. It was found that LDLR null and defective variants reduce LDL binding and uptake in activated T-lymphocytes, while LDLR missense variants affect LDLR conformational stability and the dissociation of the LDLR-ApoB complex.

GENE (2023)

Add to Collection

Article Cell Biology

Restoration of lipid homeostasis between TG and PE by the LXRα-ATGL/EPT1 axis ameliorates hepatosteatosis

Yulian Chen et al.

Summary: Regulating lipid metabolism balance to achieve a healthy lipid homeostasis may be a promising therapy for alleviating hepatosteatosis. Clinical studies have found that in obese patients with a body mass index (BMI) greater than 28, an increase in triglycerides (TG) is accompanied by a decrease in phosphatidylethanolamine (PE). Patients with high TG and low PE levels have shorter survival and poor prognosis.

CELL DEATH & DISEASE (2023)

Add to Collection

Review Biochemistry & Molecular Biology

Pharmacometabolomics for the Study of Lipid-Lowering Therapies: Opportunities and Challenges

Erica Gianazza et al.

Summary: Lipid-lowering therapies are widely used to prevent ASCVD and related mortality. Omics technologies have been employed to study the mechanisms and effects of these drugs, aiming to improve treatment efficacy and safety. Pharmacometabolomics focuses on studying the effects of drugs on metabolic pathways and the variation of treatment response. This review summarizes significant metabolomic studies on lipid-lowering therapies, including statins, fibrates, and novel drugs and nutraceutical approaches. Integrating pharmacometabolomics data with other omics approaches can help understand the biological mechanisms of lipid-lowering drugs and improve treatment efficacy while reducing side effects.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Add to Collection

Article Endocrinology & Metabolism

Approach to the Patient With a Suboptimal Statin Response: Causes and Algorithm for Clinical Management

Lufan Sun et al.

Summary: This article introduces the lipid-lowering therapy of statins in the prevention of atherosclerotic cardiovascular disease (ASCVD), but their effectiveness in lowering LDL-C can vary significantly between individuals. The different causes of a suboptimal statin response are described, and an algorithm for the diagnosis and clinical management of these patients is provided.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2023)

Add to Collection

Review Chemistry, Medicinal

Beyond Lipid-Lowering: Effects of Statins on Cardiovascular and Cerebrovascular Diseases and Cancer

Yoichi Morofuji et al.

Summary: The statins, also known as HMG-CoA reductase inhibitors, are widely used as first-line therapy for hypercholesterolemia. Apart from their lipid-lowering effect, statins have been suggested to have various pleiotropic effects, including anti-inflammatory, antioxidant, vascular endothelial function-improving, plaque-stabilizing, and platelet aggregation-inhibiting effects. They have established preventive effects on atherothrombotic stroke and potential neuroprotective effects in other cerebrovascular diseases. Additionally, statins have shown pro-apoptotic, growth-inhibitory, and pro-differentiation effects in certain malignancies.

PHARMACEUTICALS (2022)

Add to Collection

Article Pharmacology & Pharmacy

Genetic Variant ABCC1 rs45511401 Is Associated with Increased Response to Statins in Patients with Familial Hypercholesterolemia

Carolina Dagli-Hernandez et al.

Summary: In this study, the deleterious variant ABCC1 rs45511401 was found to significantly enhance the LDL-c response to statin treatment in Brazilian FH patients. However, deleterious variants in PK genes were not associated with an increased risk of statin-related adverse events. This suggests that ABCC1 rs45511401 may be a promising candidate for personalized statin therapy.

PHARMACEUTICS (2022)

Add to Collection

Article Oncology

Modulation of Plasma Lipidomic Profiles in Metastatic Castration-Resistant Prostate Cancer by Simvastatin

Blossom Mak et al.

Summary: This study found that simvastatin can modify the poor lipid profile in men with metastatic castration-resistant prostate cancer (mCRPC). Higher levels of sphingolipids, which are associated with poor prognosis, were reduced after simvastatin treatment. These findings are important for improving overall survival and therapeutic outcomes in mCRPC patients.

CANCERS (2022)

Add to Collection

Article Public, Environmental & Occupational Health

Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): A study protocol

Jessica Bassani Borges et al.

Summary: The study aims to investigate the genetic, epigenetic, and pharmacogenomic factors associated with familial hypercholesterolemia (FH) and polygenic hypercholesterolemia (PH) through various experimental methods to elucidate the pathophysiological mechanisms and improve diagnosis and treatment levels.

RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY (2021)

Add to Collection

Article Genetics & Heredity

Functional analysis of PCSK9 3′UTR variants and mRNA-miRNA interactions in patients with familial hypercholesterolemia

Bruna Los et al.

Summary: In this study, functional analysis of PCSK9 3' UTR variants and mRNA-miRNA interactions were conducted in patients with familial hypercholesterolemia (FH). It was found that PCSK9 c.*345C>T may act as a loss-of-function variant and miR-4721 and miR-564 could downregulate PCSK9 expression, potentially improving the lipid profile in FH patients.

EPIGENOMICS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights

Zhiqiang Pang et al.

Summary: MetaboAnalyst version 5.0 has been introduced to facilitate comprehensive metabolomics data analysis and interpretation, with the aim of narrowing the gap from raw data to functional insights. Three new modules have been developed to assist in this goal, along with various other new functions and improvements in interface, graphics, and codebase. Users can now easily switch between compatible modules for a streamlined data analysis experience.

NUCLEIC ACIDS RESEARCH (2021)

Add to Collection

Article Biochemistry & Molecular Biology

The Impact of Simvastatin on Lipidomic Markers of Cardiovascular Risk in Human Liver Cells Is Secondary to the Modulation of Intracellular Cholesterol

Yvette L. Schooneveldt et al.

Summary: The study found that altering cholesterol conditions affects the lipidome of liver cells, including increased levels of lipids containing arachidonic acid and decreases in phosphatidylinositol species. The PI(36:2)/PC(18:0_20:4) ratio responds to changes in intracellular cholesterol abundance, likely through a flux of the n-6 fatty acid pathway and altered phosphatidylinositol synthesis.

METABOLITES (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Worldwide Prevalence of Familial Hypercholesterolemia Meta-Analyses of 11 Million Subjects

Sabina O. Beheshti et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Add to Collection

Article Microbiology

Lipidomic Analysis Reveals Serum Alteration of Plasmalogens in Patients Infected With ZIKA Virus

Adriano Queiroz et al.

FRONTIERS IN MICROBIOLOGY (2019)

Add to Collection

Article Cardiac & Cardiovascular Systems

Coronary Artery Disease Risk and Lipidomic Profiles Are Similar in Hyperlipidemias With Family History and Population-Ascertained Hyperlipidemias

Joel T. Ramo et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)

Add to Collection

Article Multidisciplinary Sciences

Alterations in lipid metabolism of spinal cord linked to amyotrophic lateral sclerosis

Adriano Britto Chaves-Filho et al.

SCIENTIFIC REPORTS (2019)

Add to Collection

Review Biochemistry & Molecular Biology

Understanding phosphoinositides: rare, dynamic, and essential membrane phospholipids

Eamonn J. Dickson et al.

BIOCHEMICAL JOURNAL (2019)

Add to Collection

Article Medicine, Research & Experimental

Changes in plasma lipids predict pravastatin efficacy in secondary prevention

Kaushala S. Jayawardana et al.

JCI INSIGHT (2019)

Add to Collection

Article Biochemistry & Molecular Biology

Regulation of endogenic metabolites by rosuvastatin in hyperlipidemia patients: An integration of metabolomics and lipidomics

Hyunbeom Lee et al.

CHEMISTRY AND PHYSICS OF LIPIDS (2018)

Add to Collection

Article Cardiac & Cardiovascular Systems

Clinical Genetic Testing for Familial Hypercholesterolemia

Amy C. Sturm et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)

Add to Collection

Article Biochemistry & Molecular Biology

Statin action enriches HDL3 in polyunsaturated phospholipids and plasmalogens and reduces LDL-derived phospholipid hydroperoxides in atherogenic mixed dyslipidemia

Alexina Orsoni et al.

JOURNAL OF LIPID RESEARCH (2016)

Add to Collection

Article Cardiac & Cardiovascular Systems

Familial hypercholesterolaemia: A global call to arms

Antonio J. Vallejo-Vaz et al.

ATHEROSCLEROSIS (2015)

Add to Collection

Article Genetics & Heredity

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology

Sue Richards et al.

GENETICS IN MEDICINE (2015)

Add to Collection

Article Biochemistry & Molecular Biology

Statin action favors normalization of the plasma lipidome in the atherogenic mixed dyslipidemia of MetS: potential relevance to statin-associated dysglycemia

Peter J. Meikle et al.

JOURNAL OF LIPID RESEARCH (2015)

Add to Collection

Article Endocrinology & Metabolism

Dose-Dependent Effects of Rosuvastatin on the Plasma Sphingolipidome and Phospholipidome in the Metabolic Syndrome

Theodore W. K. Ng et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)

Add to Collection

Article Cardiac & Cardiovascular Systems

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease

Borge G. Nordestgaard et al.

EUROPEAN HEART JOURNAL (2013)

Add to Collection

Article Cardiac & Cardiovascular Systems

Relation of Different Measures of Low-Density Lipoprotein Cholesterol to Risk of Coronary Artery Disease and Death in a Meta-Regression Analysis of Large-Scale Trials of Statin Therapy

Jorge R. Kizer et al.

AMERICAN JOURNAL OF CARDIOLOGY (2010)

Add to Collection

Review Cardiac & Cardiovascular Systems

Pleiotropic Effects of Statins - Basic Research and Clinical Perspectives

Qian Zhou et al.

CIRCULATION JOURNAL (2010)

Add to Collection

Article Endocrinology & Metabolism

Lipidomic analysis of variation in response to simvastatin in the Cholesterol and Pharmacogenetics Study

Rima Kaddurah-Daouk et al.

METABOLOMICS (2010)

Add to Collection

Article Medicine, General & Internal

Lipidomic approach to evaluate rosuvastatin and atorvastatin at various dosages: investigating differential effects among statins

Sandrin C. Bergheanu et al.

CURRENT MEDICAL RESEARCH AND OPINION (2008)

Add to Collection

Article Biochemistry & Molecular Biology

Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics

Vitali Matyash et al.

JOURNAL OF LIPID RESEARCH (2008)

Add to Collection

Review Biochemistry & Molecular Biology

The metabolism of structured triacylglycerols

HL Mu et al.

PROGRESS IN LIPID RESEARCH (2005)

Add to Collection

Article Medicine, General & Internal

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

C Baigent et al.

LANCET (2005)

Add to Collection

© Peeref 2019-2024. All rights reserved.